Hologic has underperformed the broader market over the past year, but Wall Street analysts are moderately optimistic about the stock’s future.
Intuitive Surgical is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.
Cooper Companies has significantly underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.
IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.
Despite ResMed’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
Intuitive Surgical has outperformed the broader market by a wide margin over the past year, and analysts are moderately optimistic about the stock’s prospects.
Hologic has lagged the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
GE HealthCare is poised to reveal its second-quarter earnings results this month, and analysts foresee a modest uptick in its bottom-line figure.